Dr. Reddy's Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
P/E Ratio16.8618.4117.0330.3243.47
P/S Ratio2.933.673.123.333.95
P/B Ratio2.833.653.323.754.33
Price/Tangible Book4.244.283.924.505.64
Price/FCF50.3735.3116.1453.1328.86
Price/OCF20.5322.5613.0425.4220.99
Enterprise Value Ratios
EV/Revenue2.913.483.003.303.97
EV/EBITDA10.6712.2611.1514.8216.50
EV/EBIT12.9814.8213.7919.7022.91
EV/FCF50.1033.4915.4952.6129.04
Profitability & Returns
Return on Equity (ROE)0.19%0.22%0.21%0.13%0.11%
Return on Assets (ROA)0.10%0.12%0.11%0.08%0.08%
Return on Invested Capital (ROIC)0.20%0.25%0.22%0.15%0.13%
Return on Capital Employed (ROCE)0.20%0.23%0.23%0.18%0.18%
Leverage & Solvency Ratios
Debt/Equity0.140.070.060.180.17
Debt/EBITDA0.520.250.200.710.66
Debt/FCF2.470.690.282.521.17
Liquidity Ratios
Current Ratio1.922.582.381.931.78
Quick Ratio1.161.721.581.241.07
Efficiency Ratios
Asset Turnover0.740.790.800.770.76
Inventory Turnover2.012.062.142.092.15
Yield & Distribution Ratios
Earnings Yield0.06%0.05%0.06%0.03%0.02%
FCF Yield0.02%0.03%0.06%0.02%0.03%
Dividend Yield0.01%0.01%0.01%0.01%0.01%
Payout Ratio0.12%0.12%0.11%0.18%0.24%
Buyback Yield0.00%0.00%0.00%0.00%0.00%
Total Return0.01%0.00%0.01%0.01%0.00%